Glenmark Pharmaceuticals Launches Pioneering Nutrition Program to Fight Malnutrition in the Philippines

MANILA, Philippines, March 25, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health Futures Foundation, Inc. (HFI) and the Municipality of Malinao to launch a comprehensive initiative to improve nutrition among children and pregnant/lactating women in the Philippines. This program, titled 'Food Supplementation and Capacity Building Support for Improved Nutrition in Malinao, Aklan,' aligns with the country's national health and development goals and will cover 23 Barangays. Its focus is to reduce the number of malnourished children aged 0-5 years and to support nutritionally-at-risk pregnant and lactating women. Additionally, the program will also empower community health workers to drive behavior change and advocate for improved health and nutrition outcomes, particularly for disadvantaged families.

This initiative marks Glenmark's first major social responsibility project in the Philippines. It underscores the company's commitment to global health solutions under its guiding core belief: 'Healthy Children are the Foundation of a Healthier World.' For this program, Glenmark and HFI are collaborating with local government offices, including the Municipal Health Office, Municipal Social Welfare Development and the Municipal Agriculture Office, to ensure seamless implementation. The long-term goal is to scale these efforts beyond Malinao to other underserved areas, impacting even more communities in need.

Speaking at the launch, Hon. Josephine I. Iquina, Municipal Mayor, Malinao said, "The fight against malnutrition requires a collective effort, and we appreciate Glenmark's commitment to improving nutrition and health outcomes in vulnerable communities. This initiative is a vital step in ensuring that mothers and children receive the nutrition they need while strengthening local capacity for long-term impact. By working with partners like Health Futures Foundation and the local government, Glenmark is playing a crucial role in advancing our national health agenda."

Tomas Mihal, Vice President and Regional Business Head - Asia Pacific, Glenmark Pharmaceuticals Ltd. said, "At Glenmark, we are proud to launch our first social responsibility project in the Philippines. The initiative aims to create sustainable solutions that address the root causes of malnutrition. By combining immediate support with long-term capacity building, we aim to empower local communities and health systems to break the cycle of malnutrition."

Adeel Hasan, Country Manager - Philippines, Glenmark Philippines Inc. said, "Addressing child malnutrition and maternal health is essential for Philippines' development. By partnering with local government and HFI, we ensure that our intervention is tailored to the community needs, creating lasting benefits for Filipino families."

Dr. Jaime Galvez Tan, Chairman of Health Futures Foundation, Inc., said, "This program is more than providing immediate aid; it is about empowering communities to take charge of their own health. Through nutrition gardening, training health workers, and fostering local leadership, we are laying the foundation for a healthier, more resilient future for the Philippines."

The project's structure is centered on three key interventions and aims to impact nearly 25,000 beneficiaries through:

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. The company has 11 world-class manufacturing facilities spread across 4 continents, and operations in over 80 countries. Scrip 100 positions Glenmark amongst the Top 100 biopharmaceutical companies ranked by Pharmaceutical Sales in 2023; while Generics Bulletin places it in the Top 50 Generics and biosimilar companies ranked by sales in 2024. Glenmark's Green House Gas (GHG) emission reduction targets have been approved in 2023 by the Science Based Target initiative (SBTi), making it only the second pharmaceutical company in India to achieve this. The organization has impacted over 3.3 million lives over the last decade through its CSR interventions.

For more information, visit www.glenmarkpharma.com. You can follow us on LinkedIn (Glenmark Pharmaceuticals) and Instagram (glenmark_pharma).

About Health Futures Foundation, Inc.

Health Futures Foundation, Inc. (HFI) is a non-stock, non-profit, non-government organization involved in the design and management of health and social development projects/programs in marginalized communities in the Philippines. HFI envisions "marginalized Filipino communities and vulnerable population groups achieve and sustain optimum health and development". Its mission is "to empower marginalized sectors and lend technical assistance to local governments in achieving access, quality, and equity in health and development through actual and virtual communities of wellness". Since 1998, HFI has implemented more than 85 projects all over the Philippines including community-based health and wellness programs, design and management of community training programs, health sector reviews, health policy analysis, health planning and programming, health emergency response, qualitative health research and assessment, and health governance.

For more information, visit www.healthfuturesfoundation.com or follow HFI on on LinkedIn (Health Futures Foundation, Inc.), Facebook (healthfutures), and Instagram (healthfutures).

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Glenmark Pharmaceuticals Launches Pioneering Nutrition Program to Fight Malnutrition in the Philippines

CHICAGO, May 17, 2025 /PRNewswire/ -- Artly has unveiled new upgrades to its fully automated robotic barista, the Barista Bot, at the National Restaurant Association 2025 show (NRA). The upgrades include a more compact mini version of the Barista Bot, now only 4ft x 4ft, a bigger refrigerator for increased storage, a customizable design on its countertops to better fit the décor in different settings, and improved learning ability that allows the bot to make even more beverages.

Automation and robotics in restaurants are prominent themes at this year's NRA, and there is hardly a more striking example than of the robotic arm on Artly's mini Barista Bot pouring intricate latte art.

Designed for coffee shops, event venues, and restaurants, Artly's Barista Bot is built on Artly's Vision-Language-Action (VLA) AI model. Trained using motion capture data provided by world-class baristas, the Barista Bot can already craft 28 hot and iced beverages by replicating the artist's movements, including intricate latte art. Continuous improvements to Barista Bot's learning ability will allow for even more menu options.

The Barista Bot has served nearly 1 million cups of coffee since its first model five years ago, has raised over $10 million in funding, and can be found in 15 cafe locations across the US and major expansion plans this year. The upgrades and customization made to the new mini Barista Bot model on display at NRA 2025 were designed to help expand locations by being more versatile and more applicable. This includes countertop options in white, walnut, or the original wood coloring.  

"With these new upgrades, Barista Bot is now able to serve more drinks to more customers, becoming a natural addition to cafes that not only better fits the café's aesthetics but serves, fast, consistent and top-quality coffee." said Yushan Chen, Chief Operating Officer of Artly. "Our mission is to share culinary artistry with everyone, and we invite NRA attendees to come by and experience it firsthand."

Visit Artly to see the Barista Bot and more in action at the National Restaurant Association Show 2025 at McCormick Place in Chicago, May 17-20, booth #8739.

About Artly

Founded in 2020, Artly has transformed the coffee industry by combining advanced AI with a deep appreciation for artisanal coffee. Utilizing cutting-edge technology, the company provides authentic specialty coffee experiences through its robotic baristas. Since its inception, Artly has already generated over $5 million in coffee revenue. With a client portfolio that includes Jump Trading, Microsoft, MUJI, Nvidia, and other leading brands, Artly is poised to lead the food and beverage automation market while preserving the craftsmanship and artistry behind every cup.

To learn more, visit artly.ai

Media Contact

Cecilia Qian
Public Relations Manager
cecilia@impact5r.com

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Artly debuts mini Barista Bot at National Restaurant Association 2025 show